Literature DB >> 22450220

Current concepts in vitreomacular traction syndrome.

Juliana M Bottós1, Javier Elizalde, Eduardo B Rodrigues, Maurício Maia.   

Abstract

PURPOSE OF REVIEW: As Reese first described the vitreomacular traction (VMT) syndrome in 1970, the knowledge base about the disease has been changing over time due to the advent of the high-definition optical coherence tomography (HD-OCT). The aim of this article was to present the current information on the pathophysiology, anatomic macular abnormality associations, treatments, and new concepts in VMT syndrome. RECENT
FINDINGS: HD-OCT has provided unprecedented visualization of the vitreomacular interface, which has led to better comprehension of the VMT syndrome. The technologic advances also emphasized the need to review the basis of the VMT syndrome and define as yet unsettled and often confusing concepts.
SUMMARY: The recognition of the role of VMT in a variety of macular conditions is imperative for proper diagnosis and appropriate management of these diseases.

Entities:  

Mesh:

Year:  2012        PMID: 22450220     DOI: 10.1097/ICU.0b013e328352404c

Source DB:  PubMed          Journal:  Curr Opin Ophthalmol        ISSN: 1040-8738            Impact factor:   3.761


  8 in total

1.  Spectrum of morphological and visual changes due to vitreomacular interface disorders encountered in a large consecutive cohort of patients.

Authors:  W Fusi-Rubiano; M Awad; R Manjunath; I Elaraoud; N Narendran; Y Yang
Journal:  Eye (Lond)       Date:  2015-01-09       Impact factor: 3.775

Review 2.  Structure and mechanics of the vitreoretinal interface.

Authors:  Joseph D Phillips; Eileen S Hwang; Denise J Morgan; Christopher J Creveling; Brittany Coats
Journal:  J Mech Behav Biomed Mater       Date:  2022-08-05

3.  Spontaneous resolution of idiopathic vitreomacular traction syndrome in a healthy young man.

Authors:  Zhen Wang; Xiao Lv; Mingfeng Wu; Wei Xu; Ao Rong
Journal:  Int J Clin Exp Med       Date:  2015-07-15

Review 4.  Profile of ocriplasmin and its potential in the treatment of vitreomacular adhesion.

Authors:  Francisco R Stefanini; Maurício Maia; Paulo Falabella; Marcel Pfister; Moritz Niemeyer; Amir H Kashani; Mark S Humayun; Michael J Koss
Journal:  Clin Ophthalmol       Date:  2014-05-06

Review 5.  Patient-reported outcomes of ocriplasmin for the treatment of vitreomacular traction: a systematic review and synthesis of the literature.

Authors:  Benedicte Lescrauwaet; Koenraad Blot; Timothy L Jackson
Journal:  Patient Relat Outcome Meas       Date:  2019-03-27

6.  Pneumatic Vitreolysis for the Treatment of Vitreomacular Traction Syndrome

Authors:  Hüseyin Baran Özdemir; Şengül Özdek; Murat Hasanreisoğlu
Journal:  Turk J Ophthalmol       Date:  2019-09-03

7.  Effect of pneumatic vitreolysis in management of patients with symptomatic focal vitreomacular traction.

Authors:  Ahmed N Fouad; Iman M Eissa; Ghada A Nassar; Mahmoud Leila; Adel M Fathy
Journal:  Int J Retina Vitreous       Date:  2022-03-28

Review 8.  Idiopathic vitreomacular traction and macular hole: a comprehensive review of pathophysiology, diagnosis, and treatment.

Authors:  D H W Steel; A J Lotery
Journal:  Eye (Lond)       Date:  2013-10       Impact factor: 3.775

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.